eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Procter & Gamble (Health & Beauty Care) Ltd.

The Heights, Brooklands, Weybridge, Surrey, KT13 0XP, UK
Telephone: +44 (0)191 297 5000
Fax: +44 (0)191 297 6295
WWW: http://www.uk.pg.com
Customer Care direct line: +44 (0) 8000 850367 (UK)
Customer Care direct line: +353 (1) 800 509 301 (Ireland)

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Summary of Product Characteristics last updated on the eMC: 19/08/2010
SPC Vicks Sinex Soother

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 19/08/2010 and displayed until Current
Reasons for adding or updating:
  • Change to section 1 -Name of the Medicinal product
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   17-May-2010
Legal Category:   GSL
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 1 - Product name changed to Vicks Sinex Soother Nasal Spray

Section 4.2 -
  Posology changed to: Adults and children over 12 years: 1-2 sprays up each nostril maximum 2-3 times daily.

                                                      Not recommended for use in children under 12yrs.

Section 4.3 - Where there is demonstrated hypersensitivity or idiosyncrasy to any ingredient in the product has been replaced with 
                    In case of hypersensitivity to the active substance or to any of the excipients.

                    by children under 6 years of age has been replaced with by children under 12 years of age

Section 8 -
Marketing Authoristion Number has been changed to PL 00129/0356

Section 9 - Date of First Authorisation has been changed to 17/05/2010

Section 10 -
Revision of text has been changed to 17/05/2010

Updated on 26/10/2007 and displayed until 19/08/2010
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

Active Ingredients/Generics

 
   oxymetazoline hydrochloride